Bayesian Capital Management, LP Procept Bio Robotics Corp Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
A detailed history of Bayesian Capital Management, LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bayesian Capital Management, LP holds 10,704 shares of PRCT stock, worth $371,642. This represents 0.1% of its overall portfolio holdings.
Number of Shares
10,704Holding current value
$371,642% of portfolio
0.1%Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
291Shares Held
45.2MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$182 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$121 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$74.9 Million0.04% of portfolio
-
Chicago Capital, LLC1.57MShares$54.5 Million1.39% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$53 Million0.06% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.55B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...